華昊中天醫藥-B(02563.HK)申請公司未上市股份全流通
格隆匯5月26日丨華昊中天醫藥-B(02563.HK)公吿,董事會決議公吿申請公司未上市股份全流通。茲提述中國證券監督管理委員會於2019年11月14日發佈並於2023年8月10日進一步修訂的《H股公司境內未上市股份申請"全流通"業務指引》以及中國證監會於2023年2月17日就H股於聯交所上市的公司申請股份全流通程序發佈的《境內企業境外發行證券和上市管理試行辦法》。
在符合中華人民共和國相關法律、法規、規章及規範性文件以及上市規則的前提下,公司可應股東要求向中國證監會提出境內未上市股份全流通的申請。
本次全流通方案的決議在相關申請全流通股東出具的授權委託書有效期內有效。若相關申請全流通股東重新出具授權委託書,延長授權委託期限的,本次全流通方案的決議有效期限相應順延。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.